BDRX

Biodexa Pharmaceuticals plc

• NASDAQ·08/19 14:56

  Biodexa Surpasses Halfway Recruitment In Serenta Phase 3 Trial For FAP; Stock Up

• TipRanks·08/19 13:36

  Biodexa recruits 87 of 168 subjects in Serenta Phase 3 eRapa polyposis trial

• Seeking Alpha·08/10 23:22

  Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News

• TipRanks·07/29 21:13

  Biodexa Pharmaceuticals Restructures Share Capital and Boosts Issuance Capacity After July 29 General Meeting

• TipRanks·07/15 20:20

  Biodexa registers to sell 2.56M ADRs for holders

• TipRanks·07/09 20:48

  Biodexa Pharmaceuticals Calls July 29 General Meeting to Overhaul Share Capital Structure

• NASDAQ·07/01 05:42

  Biodexa Prices $3.5 Mln Offering Of Shares And Concurrent Private Placement Of Warrants; Stock Down

• TipRanks·06/30 20:58

  Biodexa Pharmaceuticals Investors Reject Key Resolutions at June 30 AGM

• TipRanks·06/30 13:52

  Biodexa Raises $3.5 Million via Registered Offering, Private Placement and Warrant Inducement

• TipRanks·06/30 12:21

  Biodexa Pharmaceuticals announces pricing of $3.5M registered offering

• TipRanks·06/29 13:15

  Biodexa Pharmaceuticals receives Health Canada approval for Serenta trial

• TipRanks·05/14 20:36

  Biodexa Pharmaceuticals Proposes Major Share Capital Reorganization Ahead of June AGM

• TipRanks·04/05 15:28

  Upcoming Stock Splits This Week (April 6-10, 2026) – Stay Invested

• TipRanks·04/02 23:50

  Biodexa Pharmaceuticals PLC-ADR trading halted, news pending

• NASDAQ·04/02 15:33

  Biodexa Pharmaceuticals Stock Surges 69% Over Partnership With Syngene International